Carlos Alberto Guzmán (Carlos A Guzmán, Carlos A Guzman)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Immune Response

Dendritic Cells

Listeria Monocytogenes

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Schulze, Ulrich Weber, Christoph Schuy, Marco Durante, Carlos Alberto Guzmán
Influenza Virus Inactivated by Heavy Ion Beam Irradiation Stimulates Antigen-Specific Immune Responses. Pharmaceutics 16 (4) (2024)
Matthias Hillenbrand, Christoph Esslinger, Jemima Seidenberg, Marcel Weber, Andreas Zingg, Catherine Townsend, Barbara Eicher, Justina Rutkauskaite, Peggy Riese, Carlos Alberto Guzmán, Karsten Fischer, Simone Schmitt
Fast-Track Discovery of SARS-CoV-2-Neutralizing Antibodies from Human B Cells by Direct Functional Screening. Viruses 16 (3) (2024)
Kai Schulze, Ulrich Weber, Christoph Schuy, Marco Durante, Carlos Alberto Guzmán
Influenza Virus Inactivated by Heavy Ion Beam Irradiation Stimulates Antigen-Specific Immune Responses. Pharmaceutics 16 (4) (2024)
Matthias Hillenbrand, Christoph Esslinger, Jemima Seidenberg, Marcel Weber, Andreas Zingg, Catherine Townsend, Barbara Eicher, Justina Rutkauskaite, Peggy Riese, Carlos Alberto Guzmán, Karsten Fischer, Simone Schmitt
Fast-Track Discovery of SARS-CoV-2-Neutralizing Antibodies from Human B Cells by Direct Functional Screening. Viruses 16 (3) (2024)
Matthias Hillenbrand, Christoph Esslinger, Jemima Seidenberg, Marcel Weber, Andreas Zingg, Catherine Townsend, Barbara Eicher, Justina Rutkauskaite, Peggy Riese, Carlos Alberto Guzmán, Karsten Fischer, Simone Schmitt
Fast-Track Discovery of SARS-CoV-2-Neutralizing Antibodies from Human B Cells by Direct Functional Screening. Viruses 16 (3) (2024)
Matthias Hillenbrand, Christoph Esslinger, Jemima Seidenberg, Marcel Weber, Andreas Zingg, Catherine Townsend, Barbara Eicher, Justina Rutkauskaite, Peggy Riese, Carlos Alberto Guzmán, Karsten Fischer, Simone Schmitt
Fast-Track Discovery of SARS-CoV-2-Neutralizing Antibodies from Human B Cells by Direct Functional Screening. Viruses 16 (3) (2024)
Stefan Jungbluth, William Martin, Monika Slezak, Hilde Depraetere, Carlos Alberto Guzmán, Anton Ussi, David Morrow, Fran Van Heuverswyn, Sven Arnouts, Manuel J T Carrondo, Ole Olesen, Tom H M Ottenhoff, H M Dockrell, Mei Mei Ho, Alexandre Dobly, Dennis Christensen, Joaquim Segalés, Fabrice Laurent, Frédéric Lantier, Norbert Stockhofe-Zurwieden, Francesca Morelli, Jan A M Langermans, Frank A W Verreck, Roger Le Grand, Arjen Sloots, Donata Medaglini, Maria Lawrenz, Nicolas Collin
Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact. F1000Research 12 (2023)
Stefan Jungbluth, William Martin, Monika Slezak, Hilde Depraetere, Carlos Alberto Guzmán, Anton Ussi, David Morrow, Fran Van Heuverswyn, Sven Arnouts, Manuel J T Carrondo, Ole Olesen, Tom H M Ottenhoff, H M Dockrell, Mei Mei Ho, Alexandre Dobly, Dennis Christensen, Joaquim Segalés, Fabrice Laurent, Frédéric Lantier, Norbert Stockhofe-Zurwieden, Francesca Morelli, Jan A M Langermans, Frank A W Verreck, Roger Le Grand, Arjen Sloots, Donata Medaglini, Maria Lawrenz, Nicolas Collin
Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact. F1000Research 12 (2023)
Aaqib Sohail, Azeem A Iqbal, Nishika Sahini, Fangfang Chen, Mohamed Tantawy, Syed F H Waqas, Moritz Winterhoff, Thomas Ebensen, Kristin Schultz, Robert Geffers, Klaus Schughart, Matthias Preusse, Mahmoud Shehata, Heike Bähre, Marina C Pils, Carlos Alberto Guzmán, Ahmed Mostafa, Stephan Pleschka, Christine Susanne Falk, Alessandro Michelucci, Frank Pessler
Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection. PLoS pathogens 18 (1) (2022)
Lena Kliesch, Simon Delandre, Aljoscha Gabelmann, Marcus Koch, Kai Schulze, Carlos Alberto Guzmán, Brigitta Loretz, Claus-Michael Lehr
Lipid-Polymer Hybrid Nanoparticles for mRNA Delivery to Dendritic Cells: Impact of Lipid Composition on Performance in Different Media. Pharmaceutics 14 (12) (2022)
Lena Kliesch, Simon Delandre, Aljoscha Gabelmann, Marcus Koch, Kai Schulze, Carlos Alberto Guzmán, Brigitta Loretz, Claus-Michael Lehr
Lipid-Polymer Hybrid Nanoparticles for mRNA Delivery to Dendritic Cells: Impact of Lipid Composition on Performance in Different Media. Pharmaceutics 14 (12) (2022)
Lena Kliesch, Simon Delandre, Aljoscha Gabelmann, Marcus Koch, Kai Schulze, Carlos Alberto Guzmán, Brigitta Loretz, Claus-Michael Lehr
Lipid-Polymer Hybrid Nanoparticles for mRNA Delivery to Dendritic Cells: Impact of Lipid Composition on Performance in Different Media. Pharmaceutics 14 (12) (2022)
Lena Kliesch, Simon Delandre, Aljoscha Gabelmann, Marcus Koch, Kai Schulze, Carlos Alberto Guzmán, Brigitta Loretz, Claus-Michael Lehr
Lipid-Polymer Hybrid Nanoparticles for mRNA Delivery to Dendritic Cells: Impact of Lipid Composition on Performance in Different Media. Pharmaceutics 14 (12) (2022)
Christian Lanfermann, Sebastian Wintgens, Thomas Ebensen, Martin Kohn, Robert Laudeley, Kai Schulze, Claudia Rheinheimer, Johannes H Hegemann, Carlos Alberto Guzmán, Andreas Klos
Prophylactic Multi-Subunit Vaccine against Chlamydia trachomatis: In Vivo Evaluation in Mice. Vaccines 9 (6) (2021)
Denys Pogozhykh, Dorothee Eicke, Oleksandr Gryshkov, Willem-Frederik Wolkers, Kai Schulze, Carlos Alberto Guzmán, Rainer Blasczyk, Constança Figueiredo
Towards Reduction or Substitution of Cytotoxic DMSO in Biobanking of Functional Bioengineered Megakaryocytes. International journal of molecular sciences 21 (20) (2020)
Carlos Alberto Guzmán
Next Generation Influenza Vaccines: Looking into the Crystal Ball. Vaccines 8 (3) (2020)